45 results on '"de Portu, Simona"'
Search Results
2. A European Cost–Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes
3. Advanced Hybrid Closed Loop in Adult Population With Type 1 Diabetes: A Substudy From the ADAPT Randomized Controlled Trial in Users of Real-Time Continuous Glucose Monitoring
4. Response to: Letter to the Editor with Regard to the Cost-Effectiveness of Hybrid Closed-Loop Systems Versus Multiple Daily Injections Plus Intermittently Scanned Continuous Glucose Monitoring in Type 1 Diabetes in the Netherlands
5. Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study
6. Cost-Effectiveness Analysis of an Advanced Hybrid Closed-Loop Insulin Delivery System in People with Type 1 Diabetes in Greece
7. Cost-Effectiveness of Hybrid Closed Loop Insulin Pumps Versus Multiple Daily Injections Plus Intermittently Scanned Glucose Monitoring in People With Type 1 Diabetes in The Netherlands
8. Randomised controlled trial of Advanced Hybrid Closed Loop in an Adult Population with Type 1 Diabetes (ADAPT): study protocol and rationale
9. Cost-effectiveness of a novel hybrid closed-loop system compared with continuous subcutaneous insulin infusion in people with type 1 diabetes in the UK
10. Predicting Factors Associated with Hypoglycemia Reduction with Automated Predictive Insulin Suspension in Patients at High Risk of Severe Hypoglycemia: An Analysis from the SMILE Randomized Trial
11. Farmacoeconomia
12. Cost-Effectiveness of Sensor-Augmented Insulin Pump Therapy Versus Continuous Insulin Infusion in Patients with Type 1 Diabetes in Turkey
13. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial
14. Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes
15. Cost-Effectiveness of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Patients with Poorly Controlled Type 2 Diabetes in Finland
16. Study of MiniMed 640G Insulin Pump with SmartGuard in Prevention of Low Glucose Events in Adults with Type 1 Diabetes (SMILE): Design of a Hypoglycemia Prevention Trial with Continuous Glucose Monitoring Data as Outcomes
17. Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden
18. Factors associated with improved glycemic control following continuous subcutaneous insulin infusion therapy in patients with type 2 diabetes uncontrolled with bolus-basal insulin regimens: An analysis from the OpT2mise randomized trial
19. Cost-Effectiveness of Sensor-Augmented Pump Therapy with Low Glucose Suspend Versus Standard Insulin Pump Therapy in Two Different Patient Populations with Type 1 Diabetes in France
20. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a UK perspective
21. Short-term cost analysis of complications related to glycated hemoglobin in patients with type 1 diabetes in the Italian setting
22. Valutazioni economiche di atorvastatina in prevenzione secondaria: un aggiornamento
23. Valutazione economica dello studio CARDS: un aggiornamento
24. Pharmaco-Economic Consequences of Losartan Therapy in Patients Undergoing Diabetic End Stage Renal Disease in EU and USA
25. Oral antiviral therapies are cost-effective vs. no treatment but indirect comparisons should be avoided
26. Psoriatic arthritis: Pharmacoeconomic considerations
27. Economic evaluation of temsirolimus on the basis of the results of the ARCC (Advanced Renal-Cell Carcinoma) study
28. Influence of generics in prescribing dynamics of proton pump inhibitors in general practice
29. Emerging Role of Capecitabine in Gastric Cancer
30. Notification of undesirable effects of cosmetics and toiletries
31. Amlodipine: a pharmacoeconomic review
32. The burden of renal cell cancer: A retrospective longitudinal study on occurrence, outcomes and cost using an administrative claims database
33. Epidemiological and economic aspects of diabetes in the Campania Region, Italy
34. Evaluation of antimicrobial consumption in Campania Region, Italy
35. PROVE-IT trial: economic analysis
36. IDEAL trial: economic analysis
37. Cost-utility analysis of abatacept in rheumatoid arthritis in Italy
38. Anti-polymer antibodies are inversely correlated with pain and fatigue severity in patients with fibromyalgia syndrome
39. Farmacoeconomia e malattie cardiovascolari
40. Valutazione economica dello studio TNT
41. Valutazione economica dello studio PROVE-IT
42. Valutazione economica dello studio MIRACL
43. Valutazione economica dello studio AVERT
44. Valutazione economica dello studio CARDS
45. Economic evaluation of the CARDS study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.